CSMS 55322098PGAACE OPSprocedural

U.S. Food and Drug Administration (FDA) to Process Port of Entry Corrections Through ACE and Posting of a New FDA Information Document

Published Mar 2, 2023

Summary

CBP announces an ACE enhancement allowing FDA to process Port of Entry corrections electronically, with testing beginning March 2023 and production deployment expected no earlier than April 15, 2023, alongside a new FDA guidance document for filers.

Summary is machine-generated at the linking layer for discovery only. Refer to the source bulletin for authoritative guidance.

CSMS 55322098 · full bulletin